Home ›
Trademark Categories ›
Pharmaceuticals ›
2017 ›
AV ›
AVOLLA
Trademark search for:
AVOLLA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-05-17 — Application filed
2021-05-20 — Application filed
2021-08-14 — Application filed
2021-11-12 — Examiners amendment -written
2021-11-12 — Assigned to examiner
2021-11-12 — Examiners amendment e-mailed
2021-11-12 — Notification of examiners amendment e-mailed
2021-11-12 — Examiner's amendment entered
2021-11-12 — Approved for pub - principal register
2021-12-01 — Notification of notice of publication e-mailed
2021-12-21 — Published for opposition
2021-12-21 — Official gazette publication confirmation e-mailed
2022-01-13 — Teas post publication amendment received
2022-01-26 — Assigned to petition staff
2022-02-07 — Post publication amendment - entered
2022-02-15 — Noa e-mailed - sou required from applicant
2022-07-07 — Teas revoke/app/change addr of atty/dom rep received
2022-07-07 — Attorney/dom.rep.revoked and/or appointed
2022-07-07 — Teas change of correspondence received
2022-07-26 — Sou teas extension received
2022-07-26 — Sou extension 1 filed
2022-07-26 — Sou extension 1 granted
2022-07-28 — Notice of approval of extension request e-mailed
2023-02-02 — Teas revoke/app/change addr of atty/dom rep received
2023-02-02 — Attorney/dom.rep.revoked and/or appointed
2023-02-02 — Teas withdrawal of attorney received-firm retains
2023-02-02 — Teas change of correspondence received
2023-02-06 — Sou teas extension received
2023-02-06 — Sou extension 2 filed
2023-02-06 — Sou extension 2 granted
2023-02-08 — Notice of approval of extension request e-mailed
2023-08-02 — Sou teas extension received
2023-08-02 — Sou extension 3 filed
2023-08-02 — Sou extension 3 granted
2023-08-04 — Notice of approval of extension request e-mailed
2024-02-15 — Sou extension 4 filed
2024-03-18 — Application abandoned
2024-03-18 — Application abandoned
2024-03-19 — Petition to revive-granted
2024-03-19 — Teas petition to revive received
2024-03-19 — Notice of revival - e-mailed
2024-03-19 — Sou extension received with teas petition
2024-03-19 — Teas petition to revive received
2024-04-30 — Case assigned to intent to use paralegal
2024-05-01 — Sou extension 4 granted
2024-05-02 — Notice of approval of extension request e-mailed
2024-08-14 — Sou teas extension received
2024-08-14 — Notice of approval of extension request e-mailed
2024-08-14 — Sou extension 5 granted
2024-08-14 — Sou extension 5 filed
2025-10-09 — Application abandoned
2025-10-09 — Application abandoned
2025-10-09 — Final status recorded
Owner Information
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc.
Correspondent
Laurence Rickles TEVA PHARMACEUTICALS USA, INC.
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
